N,N-Di(4-biphenylyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline>98.0%(HPLC)(T)1g

4-(4-Hydroxyphenyl)cyclohexanone>95.0%(GC)5g

Dimethyl 2,6-dimethyl-4-(4-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate, 97.0%, 1g

O-Phospho-D-serine, 95.0%, 500mg

N-{4-[(2E)-3-(dimethylamino)prop-2-enoyl]phenyl}acetamide, 95.0%, 1g

Ammonia solution 2.0 M in isopropanol, 2M, 100ml

2,4-Dichloro-6-fluorobenzoic acid, 98.0%, 1g

Dialysis systems Spectra/Por® Float-A-Lyzer® G2 Filling volume 1 ml, 50000 dalton(s), 12 Piece(s)

1-(4-Fluorophenyl)dihydro-2,4(1H,3H)-pyrimidinedione, 1g

3-(ethanesulfonyl)azetidine hydrochloride, 95.0%, 250mg

methyl 2-ethoxy-1-{[2'-(1H-1,2,3,4-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl}-1H-1,3-benzodiazole-7-carboxylate, 97%, 250mg

SQ 22536>97.0%(GC)50mg

2-(2,2,2-Trifluoroethoxy)acetic acid, 98%, 5g